LFCR

LFCR R&D Expense Growth

2.97%Fiscal year

Period ending:

LFCR FY R&D Growth (YoY)%
LFCR FY R&D Growth (YoY)130.27%-51.46%
1996-10-312026-06-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

LFCR r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 31 observations from Oct 31, 1996 to Jun 30, 2026.

Lifecore Biomedical Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
2.9668%
-3.6968%
-1.8429%
11.4428%
17.2801%
-11.8438%
-33.8741%
-10.4219%
35.1209%
31.0598%
3.4345%
-2.9983%
-22.4876%
-3.439%
3.7736%
112.6806%
18.9905%
12.7345%
5.758%
1.0519%
19.6225%
-31.8596%
0%
0%
12.0489%
-30.3663%
-19.0345%
1.7544%
-25%
100%
0%

Compare r&d expense growth

All LFCR financial metrics · LFCR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.